Baominh Vinh, MD
Pain Medicine · Houston, TXNPI 1578707303
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $27,223 of the $44,100 with a category attached, or 61.7%. It is spread thinly across 60 manufacturers, the largest accounting for just 14.6%. Reporting peaked in 2019 at $14,336 and has fallen 63.8% since, to $5,186 in 2025. Among pain medicine clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 903 payments — averaging $48.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stimwave Technologies Incorporated$6K
- Medtronic$4K
- Saluda Medical Americas, Inc.$4K
- Boston Scientific$3K
- Nevro Corp.$2K
- Vertiflex, Inc.$2K
- plus $22K from 54 others
What the payments were for
- Consulting fees$2,1005%
- Travel & lodging$13,31230%
- Food & beverage$27,22362%
- Education$140%
- Gifts$2491%
- Entertainment$1,2013%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Intracept$5,209
- Evoke SCS$2,379
- Superion ISS$1,840
- SPECTRA WAVEWRITER$1,579
- NURTEC ODT$1,546
- Senza$1,445
- SYNCHROMEDII$1,308
- DSUVIA$1,155
- Evoke$800
- HA MINUTEMAN G3-R$750
- INTELLIS$747
- WaveWriter Alpha Prime 16$731
- Nalu Neurostimulation System$652
- mild Device Kit$627
- PROCLAIM$575
- ReActiv8$510
- INTELLIS ADAPTIVESTIM$445
- SACROILIAC JOINT FUSION SYSTEM$352
- PAINTEQ$348
- Proclaim Family of SCS IPGs$306
How this compares
$44,100 in reported general payments places this provider in the 95th percentile of 583 pain medicine providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| BelbucaBuprenorphine Hcl | 86 | $70,503 |
| Nurtec OdtRimegepant Sulfate | 42 | $69,344 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 1,872 | $56,657 |
| Xtampza ErOxycodone Myristate | 40 | $36,684 |
| LinzessLinaclotide | 55 | $29,803 |
| Lidocaine | 317 | $26,006 |
| Buprenorphine | 116 | $25,008 |
| OxycontinOxycodone Hcl | 22 | $24,236 |
| MovantikNaloxegol Oxalate | 53 | $21,022 |
| HorizantGabapentin Enacarbil | 23 | $20,922 |
| Fentanyl | 174 | $18,620 |
| Aimovig AutoinjectorErenumab-Aooe | 19 | $13,979 |
| Gabapentin | 951 | $13,051 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 415 | $11,936 |
| Oxycodone Hcl | 510 | $10,684 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Collegium Pharmaceutical, Inc.Belbuca, Xtampza Er | $818 | $107,187126 claims |
| PfizerNurtec Odt | $463 | $69,34442 claims |
| AbbVieLinzess | $1,329 | $29,80355 claims |
| Redhill Biopharma Inc.Movantik | $47 | $21,02253 claims |
| Arbor Pharmaceuticals, Inc.Horizant | $107 | $20,92223 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 583 pain medicine providers in Texas.
Other pain medicine in Houston
- Grant ChenHouston$175K
- Gunjan PatelHouston$166K
- Jaideep MehtaHouston$134K
- David LeimanHouston$131K
- Daniel PakHouston$117K
- Mitchell EngleHouston$72K
- Mayur KanjiaHouston$46K
- Matthew ChungHouston$26K
- Thuan DaoHouston$23K
- Melissa MurphyGrapevine$653K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.